We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
No events to show.
Consensus vs. actual, and revenue trend
Rating & price-target changes
Stored first · Google News · Yahoo Finance (English)
Polomar Health Services, Inc. 2026 Q1 Financial Report: Reverse Recapitalization, Pharmacy Merger, and Growth in Compounded Prescription Services - Minichart
Polomar Health Services, Inc. 2026 Q1 Financial Report: Reverse Recapitalization, Pharmacy Merger, and Growth in Compounded Prescription Services Minichart
Polomar Health Services, Inc. 1Q 2026: Revenue $1.01M, EPS $(0.00) — 10-Q Summary - TradingView
Polomar Health Services, Inc. 1Q 2026: Revenue $1.01M, EPS $(0.00) — 10-Q Summary TradingView
Polomar Health Services, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Polomar Health Services, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 marketscreener.com
[10-Q] Polomar Health Services, Inc. Quarterly Earnings Report - Stock Titan
[10-Q] Polomar Health Services, Inc. Quarterly Earnings Report Stock Titan
Polomar Health Services modifies Altanine merger terms and CEO contract - Investing.com
Polomar Health Services modifies Altanine merger terms and CEO contract Investing.com
PMHS SEC Filings - Polomar Health 10-K, 10-Q, 8-K Forms - Stock Titan
PMHS SEC Filings - Polomar Health 10-K, 10-Q, 8-K Forms Stock Titan
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-0.02 | — | — | $37.95K | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-0.01 | — | — | $28.11K | Reported |
| FY2025 Q1 | 2024. 03. 31. | Time TBD | — | $-0.01 | — | — | $13.61K | Reported |
| FY2024 Q3 | 2023. 09. 30. | Time TBD | — | $-0.01 | — | — | $24.56K | Reported |
No research actions to show.
As of FY2025Q3 · Source: SEC/DART + price data
No holdings data to show.